NRNisha Aynikkattil Ravindran

Nisha Aynikkattil Ravindran

*This is an algorithmically generated author record based on publicly available information.

Nisha Aynikkattil Ravindran has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Acute dermal toxicity evaluation of eugenol-incorporated hydrogel in Sprague Dawley rats

    by Pooja Krishna Kizhekku Veettil, Suja Rani Sasidharan, Nisha Ayinikkattil Ravindran, Preethy John, Anoopraj Rajappan, Reji Varghese

    Background: Multidrug-resistant Staphylococcus aureus (MDRSA) infections significantly impair wound healing, often leading to chronic wounds and systemic complications. There is a need for wound dressings that are not only antibacterial but also biocompatible. Essential oils, such as eugenol, possess potent antibacterial properties, but their direct application is limited by volatility and instability. Incorporating eugenol into a polymeric hydrogel provides a stable delivery system, while ensuring safety prior to in vivo use is essential. Objectives: This study aimed to evaluate the dermal safety of eugenol-incorporated chitosan-PVA hydrogel (Eug-CH) in Sprague Dawley rats, following OECD Test Guideline 402. Materials and Methods: The inert chitosan-PVA hydrogel was synthesised via chemical crosslinking, followed by incorporation of eugenol as an emulsion. Acute dermal toxicity testing was conducted according to OECD 402, with topical application to the dorsal skin under semi-occlusive conditions. Sequential doses up to 2000 mg/kg were administered, with a total of five female rats used. Animals were monitored intensively for 24 h post-application and daily for 14 days, assessing dermal integrity, behaviour and systemic signs of toxicity. Results: Topical application of Eug-CH produced no mortality or toxicity at doses up to the tested limit dose of 2000 mg/kg. Observations over 14 days revealed no adverse effects, including erythema, edema, tremors, convulsions, or behavioural abnormalities. Gross necropsy showed no organ abnormalities and a normal increase in body weight was noted. These findings indicate that the Eug-CH formulation is safe for dermal application in rats even upto the limit dose level. Conclusion: The Eug-CH hydrogel showed no mortality, skin irritation or pathological changes at doses ranging from 200 to 2000 mg/kg, with normal body weight gain observed over 14 days. With an LD₅₀ exceeding 2000 mg/kg, the formulation is classified as GHS Category 5 (low hazard), confirming its safety for regulatory purposes. These results indicate that the eugenol incorporated hydrogel is highly biocompatible and suitable as an antibacterial wound dressing without risk of dermal toxicity.

  • Open Access

    Qualitative and quantitative phytochemical analysis of methanolic extract of Manilkara zapota leaves

    by Jhancirani Neelamegam, Preethy John, Nisha Aynikkattil Ravindran, Suja Rani Sasidharan, Indira Sukumaran Sajitha, Pratheesh Mankuzhy Damodaran

    Background: Medicinal plants are valuable sources of structurally diverse bioactive compounds that contribute significantly to drug discovery and development. Manilkara zapota has been traditionally used for various therapeutic purposes; however, comprehensive chemical characterization of its leaf extract remains limited. Objective: To preliminary phytochemical screening to determine the main classes of secondary metabolites in the extract, along with the determination of predominant functional groups by FTIR spectroscopy and the identification of bioactive compounds using GC-MS to explore the chemical composition of extract. Materials and Methods: Shade-dried leaves of M. zapota were extracted with methanol using a Soxhlet apparatus. Co-extracted latex constituents were removed by acid-induced coagulation. Preliminary phytochemical screening was performed on both latex-removed and untreated extracts. FTIR spectroscopy was employed to identify major functional groups, while GC-MS analysis was carried out to characterise bioactive constituents. Results: Qualitative screening revealed the presence of steroids, terpenoids, alkaloids, tannins, phenolic compounds, flavonoids and saponins. FTIR analysis confirmed the presence of functional groups corresponding to alcohols, alkanes, conjugated alkenes and esters. GC–MS analysis identified several bioactive compounds, including glycopeptide derivatives, phenolic compounds, fatty acid esters, monoglycerides and terpenoid constituents. Conclusion: The findings demonstrate that M. zapota leaves are rich in diverse phytochemicals, supporting their potential therapeutic applications.

  • Gas chromatography-mass spectrometric profiling of hexane fraction of whole plant Tragia involucrata L. and methanol fraction of Psidium guajava L. leaves

    by Pallavi B. Pillai, Bibu J Kariyil, A.R. Nisha, Suresh N. Nair, M Shynu, Ss Devi

    Background: Medicinal plants are an important source of bioactive compounds with significant therapeutic potential, forming the basis of many traditional and modern pharmacological preparations. Tragia involucrata and Psidium guajava are widely used in traditional medicine for treating gastrointestinal, respiratory, metabolic, and infectious conditions. Despite their traditional relevance, a detailed chemical characterization of specific solvent fractions, particularly using advanced analytical methods, remains limited. Gas chromatography–mass spectrometry (GC-MS) offers a powerful tool for the identification of volatile and semi-volatile phytochemicals that may contribute to the pharmacological properties of these plants. Objective: This study aimed to identify and characterize the bioactive phytoconstituents present in the hexane fraction of Tragia involucrata whole plant and the methanol fraction of Psidium guajava leaves using GC-MS analysis, and to highlight their potential pharmacological relevance. Materials and Methods: Whole plant material of T. involucrata and leaves of P. guajava were collected from Kollam, Kerala, authenticated through DNA barcoding, shade-dried, powdered, and extracted using methanol. The crude extracts were successively fractionated with solvents of increasing polarity, and the hexane fraction of T. involucrata and methanol fraction of P. guajava were selected for GC-MS profiling. Analyses were carried out using a Shimadzu Nexus GC-2030 system under optimized temperature and carrier gas conditions. Compounds were identified based on retention time, mass spectral data, and comparison with the NIST 20 library. Results: GC-MS analysis of the T. involucrata hexane fraction identified fourteen phytoconstituents representing diverse chemical classes. These included alkylated phenols (2,4-di-tert-butylphenol; benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy, methyl ester), terpenoids (neophytadiene), diterpene alcohols (3,7,11,15-tetramethyl-2-hexadecen-1-ol), and fatty acid derivatives such as hexadecanoic acid methyl ester, methyl stearate, 9,12-octadecadienoic acid (Z,Z) methyl ester, 9,12,15-octadecatrienoic acid (Z,Z,Z) methyl ester, and n-hexadecanoic acid. Higher-chain esters, including hexadecanoic acid bis(2-ethylhexyl) ester, were also present. Additionally, phytol, squalene, and the antioxidant dl-α-tocopherol were detected, reflecting the chemical richness and potential bioactivity of the extract. The methanol fraction of P. guajava identified 10 bioactive compounds, predominantly saturated fatty acids (tetradecanoic, pentadecanoic, octadecanoic acids, oleic acid), long-chain hydrocarbons (dotriacontane, pentacosane), triterpene (squalene) and saturated fatty acids namely 13-docosenamide, and tetradecyl palmitate. The presence of these structurally diverse metabolites in both the T. involucrata hexane fraction and the P. guajava methanolic fraction highlights their notable phytochemical abundance and potential relevance for broad pharmacological applications. Conclusion: GC-MS profiling of T. involucrata and P. guajava demonstrates a diverse array of pharmacologically important metabolites, including diterpenes, terpenoids, phenolic derivatives, fatty acid esters, squalene, and α-tocopherol. These findings support their traditional medicinal relevance and indicate their promise as sources of bioactive lead molecules for drug development. Further biological evaluation is recommended to validate their therapeutic potential.

  • In silico assessment of wound healing activity of phytochemicals from methanolic extract of Plectranthus amboinicus (Lour.) Spreng

    by Anoopa Satheesan, Siyana Saleem P, Suresh N Nair, Bibu John Kariyil, Ar Nisha, Deepthi Vijay, Ks Prasanna

    Background: Evaluating the wound healing potential of ligands present in a crude extract through molecular docking studies targeting TNF-α, IL-1β, and TGF-β1 is highly informative. TNF-α and IL-1β are key pro-inflammatory cytokines involved in the inflammatory phase of wound healing, whereas TGF-β1 plays a crucial role in tissue regeneration and remodelling. By assessing the binding affinity and interactions of the extract's phytochemicals with these proteins, valuable insights into the extract's potential anti-inflammatory and regenerative effects can be gained. This approach facilitates a targeted evaluation of the extract's capacity to modulate critical pathways in wound healing, thereby providing essential information for developing effective therapeutic agents. Aims and Objectives: Molecular docking studies on phytochemicals derived from the methanolic extract of Plectranthus amboinicus targeting TNF-α, IL-1β, and TGF-β1 provide insights into the potential wound healing efficacy of the Plectranthus amboinicus leaf extract, as reflected by the obtained docking scores. Materials and Methods: Chemical profiling of the methanolic leaf extract of Plectranthus amboinicus was conducted using GC-MS. In silico molecular docking studies with AutoDock4 were employed to evaluate the binding of these phytoconstituents to the active sites of three proteins associated with wound healing: TNF-α, TGF-β1, and IL-1β. Additionally, the pharmacokinetic properties of the active compounds were further assessed using the admetSAR software. Results and Conclusion: Of the compounds identified by GC-MS analysis, 13 exhibited promising binding scores, indicating a hopeful wound healing potential for the plant. AdmetSAR predictions further suggested that these phytoconstituents possess favourable absorption, distribution, and metabolism profiles, with low toxicity. Collectively, these findings suggest that the methanolic leaf extract of Plectranthus amboinicus holds significant wound healing activity.

  • Proteoglycans in breast cancer, identification and characterization by LC‐MS/MS assisted proteomics approach: A review

    by Ajeeshkumar Kizhakkeppurath Kumaran, Ankita Sahu, Astha Singh, Nisha Aynikkattil Ravindran, Niladri Sekhar Chatterjee, Suseela Mathew, Saurabh Verma

    Purpose: Proteoglycans (PGs) are negatively charged macromolecules containing a core protein and single or several glycosaminoglycan chains attached by covalent bond. They are distributed in all tissues, including extracellular matrix (ECM), cell surface, and basement membrane. They are involved in major pathways and cell signalling cascades which modulate several vital physiological functions of the body. They have also emerged as a target molecule for cancer treatment and as possible biomarkers for early cancer detection. Among cancers, breast cancer is a highly invasive and heterogenous type and has become the major cause of mortality especially among women. So, this review revisits the studies on PGs characterization in breast cancer using LC‐MS/MS‐based proteomics approach, which will be further helpful for identification of potential PGs‐based biomarkers or therapeutic targets.Experimental design: There is a lack of comprehensive knowledge on the use of LC‐MS/MS‐based proteomics approaches to identify and characterize PGs in breast cancer.Results: LC‐MS/MS assisted PGs characterization in breast cancer revealed the vital PGs in breast cancer invasion and progression. In addition, comprehensive profiling and characterization of PGs in breast cancer are efficiently carried out by this approach.Conclusions: Proteomics techniques including LC‐MS/MS‐based identification of proteoglycans is effectively carried out in breast cancer research. Identification of expression at different stages of breast cancer is a major challenge, and LC‐MS/MS‐based profiling of PGs can boost novel strategies to treat breast cancer, which involve targeting PGs, and also aid early diagnosis using PGs as biomarkers.


  • Evaluation of acute oral toxicity of lemon grass oil and citral in albino rats

    by Adheena Xavier, S Suja Rani, R Shankar, Ar Nisha, S Sujith, R Uma

    Essential oils, which are the plant derived secondary metabolites have been reported for various traditional medicinal applications. Amongst them, lemongrass oil (LGO) derived from Cymbopogon spp. as well as its major constituent citral possess a myriad of therapeutic potentials. The present study has been undertaken to study the adverse effects of LGO and citral on acute oral exposure to Sprague Dawley rats to establish the preliminary safety of these compounds prior to their efficacy evaluation against fatty liver disease. The toxicity study was conducted as per OECD guidelines No. 420. The LGO and citral were solubilized in 1% tween 80 and administered orally in a sequential manner in one animal at 2000 mg/kg (sighting study) followed by four animals (main study). The animals were then monitored for any clinical abnormalities or mortality and body weight gain during the observational period of 14- days, after which the animals were sacrificed and examined for abnormal lesions. LGO was further subjected to gas chromatography-mass spectrometry (GC-MS) analysis to characterize its chemical constituents, which revealed alpha and beta citral as the two major constituents. The rats treated with LGO and citral survived throughout the study period and didn’t exhibit any clinical abnormalities. Moreover, body weight gain was comparable to the vehicle treated rats and necropsy revealed no pathological alterations. Thus, the present study indicated LGO and citral as safe compounds with an LD50 greater than 2000 mg/kg and could be labelled as category 5/unclassified in hazard category of Globally harmonized system for classification of chemicals.